Mapping large numbers of results may take a few moments.
Search Results
Showing 501 - 530 of 530 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Upstream Biotechnology Inc. | Activity: Research and Development | Company Description Upstream Biotechnology uses patented technology to develop broad-spectrum disease resistant crops to eliminate pesticide use, reduce production cost and increase crop yield. | Location Sanford | |
Company URO-1 Inc. | Activity: Research and Development | Company Description URO-1 develops breakthrough products for office procedures for urology and urogynecology, which improve clinical outcomes, enhance patient experience and increase procedure efficiency. | Location Greensboro | |
Company ValanBio Therapeutics Inc. | Activity: Research and Development | Company Description Valanbio Therapeutics is an early-stage anti-infectives company. Valanbio is developing novel antibiotics for Gram-negative organisms. | Location Durham | |
Company Vascular BioSciences Inc. | Activity: Research and Development | Company Description Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases. | Location Durham | |
Company Vast Therapeutics | Activity: Research and Development | Company Description Vast Therapeutics uses a nitric oxide technology for the treatment of cystic fibrosis and other respiratory diseases. | Location Durham | |
Company Velo Bio LLC | Activity: Research and Development | Company Description Velo Bio is developing an orphan drug for the treatment of severe preeclampsia in pregnant women. | Location Morrisville | |
Company Verb Biotics LLC | Activity: Research and Development | Company Description Verb Biotics identifies and designs new strains of probiotics and postbiotics for nutrition, health and wellness. | Location Durham | |
Company Verdesian Life Sciences LLC (Cary) | Activity: Research and Development | Company Description Verdesian Life Sciences develops agricultural products with a focus in plant health, inoculants, seed treatment and nutrition. | Location Cary | |
Company Verdesian Life Sciences LLC (RTP) | Activity: Research and Development | Company Description Verdesian Life Sciences' lab in RTP focuses on the exploration of emerging and disruptive technologies to improve plant nutrient use efficacy, agriculture productivity and environmental sustainability. | Location Research Triangle Park | |
Company Verinetics Inc. | Activity: Research and Development | Company Description Verinetics is commercializing platform technology that makes dispensing controlled substance pharmaceuticals safer for patients and their providers. | Location Research Triangle Park | |
Company Verona Pharma Inc. | Activity: Research and Development | Company Description Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of respiratory diseases such as chronic obstructive pulmonary fibrosis (COPD) and cystic fibrosis (CF). | Location Raleigh | |
Company Viamer Biosciences | Activity: Research and Development | Company Description Viamer Biosciences develops advanced and proprietary biomaterials for controlled release drug delivery and regenerative medical devices. | Location Durham | |
Company ViiV Healthcare | Activity: Research and Development | Company Description ViiV Healthcare, a joint venture established by GSK and Pfizer, researches and develops new HIV medicines and advances care for people living with HIV. | Location Durham | |
Company ViraTree LLC | Activity: Production and Manufacturing | Company Description ViraTree acquires, authenticates, preserves, develops and distributes virological materials, information and technology for the advancement of virus research. | Location Research Triangle Park | |
Company ViroKyne Therapeutics LLC | Activity: Research and Development | Company Description Virokyne is developing novel therapies for the treatment of viral diseases. | Location Durham | |
Company Vital Plan Inc. | Activity: Research and Development | Company Description Vital Plan formulates and produces natural supplements and herbal therapies that support immune health, microbiome balance, and healthy aging. | Location Raleigh | |
Company Vizma.AI | Activity: Research and Development | Company Description Vizma.AI provides diagnostic molecular insights to oncologists, cardiologists and neurologists with non-invasive and patient-centric technology. | Location Chapel Hill | |
Company Vogenx Inc. | Activity: Research and Development | Company Description Vogenx is a clinical stage pharmaceutical company developing a molecule to address post-bariatric hypoglycemia. | Location Durham | |
Company vTv Therapeutics LLC | Activity: Research and Development | Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. | Location High Point | |
Company Xilis Inc. | Activity: Research and Development | Company Description Xilis is developing microfluidic droplet-based patient-derived organoid (MDPDO) technology to guide precision therapy for cancer patients and accelerate drug discovery. | Location Durham | |
Company Xollent Biotech Inc. | Activity: Research and Development | Company Description Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. | Location Cary | |
Company Xona Microfluidics Inc. | Activity: Research and Development | Company Description Xona Microfluidics develops and manufactures microfluidic platforms for neuroscience research. | Location Research Triangle Park | |
Company Xsome Biotech Inc. | Activity: Research and Development | Company Description Xsome Biotech is developing inhalable vaccines using a lung-derived exosome. | Location Cary | |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill | |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill | |
Company Zoetis Inc. | Activity: Production and Manufacturing | Company Description Zoetis develops and manufactures vaccines and medications for animal health. The Durham site develops and manufactures high-throughput automation biodevices for the poultry industry, including in ovo vaccination technology. | Location Durham | |
Company Zoion Pharma Inc. | Activity: Research and Development | Company Description Zoion Pharma develops drugs for veterinary disorders. Zoion's lead product is an epithelial sodium channel blocker compound to treat canine keratoconjunctivitis sicca (KCS) or dry eye. | Location Raleigh | |
Company ZY Therapeutics Inc. | Activity: Research and Development | Company Description ZY Therapeutics is developing a drug delivery platform for cancer therapeutics using nanotechnology. | Location Research Triangle Park | |
Company Zymeron Corporation | Activity: Research and Development | Company Description Zymeron develops and commercialize technologies to detect, prevent and treat infectious diseases, immune disorders and emerging pathological threats. | Location Durham | |
Company Zymtronix Inc. | Activity: Research and Development | Company Description Zymtronix provides technology that can enable and improve any biocatalytic reaction involving single enzymes or cell-free systems of multiple enzymes. Zymtronix offers solutions for various industries, including agriculture, life sciences, and ingredients. | Location Research Triangle Park |